News
02 Nov / 2022

OBM Genetics Welcomes New Editorial Board Member

We sincerely welcome Dr. Masahiro Sato, from National Center for Child Health and Development (NCCHD), Japan, to join the Editorial Board of OBM Genetics. He obtained his PhD in Biochemistry from the Kagoshima University School of Medicine, and later spent ten years at the Laboratory for Pathobiology, Pharma Research Laboratories, Hoechst Japan Ltd. (Kawagoe, Saitama, Japan), where he produced disease mouse models for Alzheimer’s disease and osteoporosis. In April 1996 - March 2006, he spent at the Department of Molecular Life Science, Tokai University School of Medicine (Isehara, Kanagawa, Japan) as Professor (Assistant), where he engaged in developing novel technologies, as exemplified by cell-lineage analysis in mammals using Cre-loxP system and testis-mediated gene transfer (TMGT), a technique without using microinjection-based transgenesis. In April 2006 - March 2021, he spent at the Gene Expression Regulation Section, Frontier Science Research Center, Kagoshima University (Kagoshima, Japan) as Professor, where he engaged in developing novel technologies related to reproduction and molecular biology as well as producing genetically modified piglets suitable for xenotransplantation. Notably, during these periods, he and his colleague Prof. Masato Ohtsuka (Tokai University School of Medicine) succeeded in developing i-GONAD, a novel method for creating genome-edited animals through in vivo genome editing. In April 2021 – Present, he is studying reproduction engineering-related research at NCCHD as Senior Fellow. We appreciate Dr. Masahiro Sato for his participation and support.

28 Oct / 2022

OBM Genetics Welcomes New Editorial Board Member

We sincerely welcome Professor Ying S. Zou from Johns Hopkins University, USA, to join the Editorial Board of OBM Genetics. Her areas of clinical expertise include the diagnosis of genetic abnormalities in patients with cancer or congenital diseases. Dr. Zou serves as Director of the Cytogenetics and Cytogenomics Laboratory at The Johns Hopkins Hospital, Director of the Cancer Cytogenetics Laboratory, Director of Cytogenomic Research Core, and Associate Director of Molecular Diagnostics Laboratory, Johns Hopkins Genomics. She is interested in the development of clinical cytogenomic and molecular genetics laboratory tests that can be used in the clinical setting for better patient care, personalized medicine, as well as for discovering disease variants and novel cancer biomarkers. As a member of the American Board of Medical Genetics and Genomics, certified in Clinical Cytogenetics and Clinical Molecular Genetics, Dr. Zou is active in the training of residents and fellows in several training programs, as well as students for clinical cytogenetics, molecular genetics, pharmaco-genomics and personalized medicine. She was recognized with The Best Attending Pathologist Teacher in Clinical Pathology by University of Maryland in 2017-2018. She is an active committee member of professional societies such as American College of Medical Genetics and Genomics (ACMG), Association for Molecular Pathology (AMP), College of American Pathologists (CAP), Cancer Genomics Consortium (CGC), and Association of Genetic Technologists (AGT), etc., as well as an editor, board member, and associate editor for several professorial journals. We appreciate Professor Zou for her participation and support.

30 Aug / 2022

OBM Genetics Welcomes New Editorial Board Member

We sincerely welcome Prof. Bruce O'Hara, from the University of Kentucky, USA, to join the Editorial Board of OBM Genetics. He obtained his PhD in Human and Mammalian Genetics from The Johns Hopkins School of Medicine, and later spent twelve years at the Stanford University Center for Sleep and Circadian Neurobiology where he established a research program directed towards an understanding of sleep using higher throughput behavioral and genomic methodologies. He currently has over 35 years of experience in mammalian genetics and especially mouse models of human disease, and has over 95 publications in areas ranging from the effects of drugs to large-scale genetic screens and models of neurodegenerative disorders. We appreciate Dr. O'Hara for his participation and support.

14 Apr / 2022

OBM Genetics Welcomes New Editorial Board Member

We sincerely welcome Prof. Yuri Shavrukov, from Flinders University, Australia, to join the Editorial Board of OBM Genetics. Originally, Prof. Shavrukov worked at the Institute of Cytology and Genetics, Russian Academy of Sciences, Novosibirsk (Russia), where he received his PhD degree (1991). In 2001, he was selected and employed by CSIRO (Commonwealth Scientific and Industrial Research Organisation), Adelaide, Australia. After CSIRO, he received a position at the University of Adelaide, Plant Genomics Centre (2005-2016), and since that he moved to Flinders University, Adelaide. Currently, Prof. Yuri Shavrukov is working at Flinders University with some collaborative international research projects. His research interests include plant genetics and genomics, gene structure and expression analysis in plants, development and application of molecular markers in plant biology. We appreciate Prof. Shavrukov for his participation and support.

14 Apr / 2022

OBM Genetics Welcomes New Editorial Board Member

We sincerely welcome Dr. Mohan Shri Jain from University of Helsinki, Finland, to join the Editorial Board of OBM Genetics. He received his M. Phil, 1973 and Ph.D., 1978, Jawaharlal Nehru University, New Delhi, India. He was a postdoctoral fellow in Israel, USA, and visiting Professor in Japan, Malaysia, Germany, and Italy. He was a Technical Officer at, International Atomic Energy Agency (IAEA), Vienna, Austria, from 1999-to 2005. He is on the Editorial Board and a reviewer in several well-reputed journals. His publications are over 170 in peer-reviewed journals, book chapters, and conference proceedings, and edited 68 books; invited speakers, and acted as a chairperson in several international conferences worldwide. In commemoration of the awarding IAEA of the Nobel Peace Prize in 2005, as a team member, he received this certificate; consultant to IAEA, the European Union, The Government of Grenada, and the Egyptian Government. His current research interests are on in vitro techniques, mutagenesis, transgenics, genetic diversity and conservation, climate change, and food security. We appreciate Dr. Jain for his participation and support.

07 Apr / 2022

OBM Genetics Welcomes New Editorial Board Member

We sincerely welcome Dr. Paola Ungaro, from National Research Council, Italy, to join the Editorial Board of OBM Genetics. Dr. Ungaro is a Researcher at the National Research Council (CNR) in Institute for Experimental Endocrinology and Oncology “Gaetano Salvatore” of Naples, Italy. Dr Ungaro’s research interest includes epigenetic and transcriptional regulation of obesity and diabetes related genes and epigenetic regulation by natural compounds. The research activity includes three main research lines: 1. Evaluation of the effects of High-Fat Diet (HFD) on the expression of genes codifying for enzymes known to induce histone post-translational modifications (PTMs). 2. Study of the effects of Polyphenols on the epigenetic regulation of obesity-related genes and on the expression of key enzyme involved in chromatin remodelling. 3. Study of the effects of Polyphenols on the expression of genes involved in the browning of white adipose tissue.  We appreciate Dr. Ungaro for her participation and support.

21 Mar / 2022

OBM Genetics Welcomes New Editorial Board Member

We sincerely welcome Prof. Dr. Yan Sanders, from University of Alabama at Birmingham, United States, to join the Editorial Board of OBM Genetics. Dr. Sanders is currently Associate Professor of Medicine. Her main research interests are epigenetic mechanisms in tissue injury, repair and aging. Her ongoing projects include exploring epigenetic alterations in pulmonary fibrosis, examining the effects of histone modifier on fibrotic lung fibroblasts, determining the epigenetic mechanisms of cellular senescence, aging, and age-related chronic diseases, specifically histone modifications and DNA methylation. We appreciate Prof. Sanders for her participation and support.

21 Mar / 2022

OBM Genetics Welcomes New Editorial Board Member

We sincerely welcome Professor Shin Murakami from Touro University California, USA, to join the Editorial Board of OBM Genetics. Professor Murakami received his Ph.D. from Kyoto University, Japan. He then worked at the University of Colorado-Boulder, University of Michigan-Ann Arbor, University of Louisville, among others. Current research interest is to understand the transition of aging processes from normal aging to disease (including Alzheimer’s disease, AD), using semi-automated imaging systems (Machino et al., 2014) and big data analysis of dementia genes in humans and C. elegans (Vahdati et al., 2017). He has formulated the multiplex stress resistance theory of aging, which has now been extended to the middle-life crisis theory of aging.  Importantly, the middle-life crisis theory predicted the outcome of one or more clinical trials in the Alzheimer's disease. Recently he accepted new national leadership roles, including Public Policy Representative of BS Section Executive Committee (Gerontology Society of America); and Committee and Task Force/New Comprehensive Foundational Sciences Examination (NBOME). We appreciate Professor Murakami for his participation and support.

18 Mar / 2022

OBM Genetics Welcomes New Editorial Board Member

We sincerely welcome Professor Penna Suprasanna, former-Head of Nuclear Agriculture & Biotechnology Division, BARC, Mumbai & Homi Bhabha National Institute, India, to join the Editorial Board of OBM Genetics. Prof. Suprasanna obtained his MSc (Genetics) and Doctorate in Genetics from Osmania University, Hyderabad (India) and did his post-doc research in the Laboratory of Tropical Crop Improvement, Cathloic University of Leuven, Leuven, Belgium. His research interests include plant stress biology, biotechnology, plant mutagenesis and plant genomics. He has made concerted efforts to apply radiation mutagenesis techniques in plants in collaboration with International Atomic Energy Agency (IAEA), Vienna. He is the recipient of the “Award of Scientific and Technical Excellence” by the Department of Atomic Energy, Government of India, and is the Fellow of International Society of Environmental Botany. Dr. Suprasanna has a patent; published more than 300 research papers/articles in national and international journals, has edited special issues for journals & books. We appreciate Professor Suprasanna for his participation and support.

16 Aug / 2018

OBM Genetics Welcomes New Editorial Board Member

We sincerely welcome Professor John Marshall from Institute of Ophthalmology (UCL), United Kingdom to join the Editorial Board of OBM Genetics. Professor Marshall has extensive experience in ophthalmology, inherited retinal disease, diabetes, glaucoma, neurodegenerative diseases, etc. We are very grateful to Prof. Marshall for his participation and support.

TOP